Ariel Investments is also relatively very bullish on the stock, dishing out 0.07 percent of its 13F equity portfolio to CPIX. Among these funds, Ariel Investments held the most valuable stake in ...

Cumberland Pharmaceuticals (CPIX) closed the most recent trading day at $5.30, moving -1.6% from the previous trading session. This move lagged the S&P 500's daily gain of 0.19%. At the same time, the ...

CPIX finally put some of its cash to work, acquiring VIBATIV from Theravance Biopharma. But the acquisition seems risky, given Theravance's commentary regarding the drug, and the rest of the portfolio ...

CPIX's bull case looks impressive on its face: huge cash balance, trailing twelve-month profits, four quarters of double-digit revenue growth, and a diversified drug portfolio, including four phase II ...

Specialty pharmaceutical companies continue to operate in a competitive healthcare environment influenced by evolving regulatory standards, product innovation and demand for differentiated therapies.

In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $6.19, marking a -0.16% move from the previous day. This change lagged the S&P 500's 0.3% gain on the day. At the same time, ...

In the latest trading session, Cumberland Pharmaceuticals (CPIX) closed at $5.67, marking a +1.61% move from the previous day. This change outpaced the S&P 500's 0.64% gain on the day. Elsewhere, the ...